0001209191-18-035407.txt : 20180604 0001209191-18-035407.hdr.sgml : 20180604 20180604205501 ACCESSION NUMBER: 0001209191-18-035407 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180523 FILED AS OF DATE: 20180604 DATE AS OF CHANGE: 20180604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MECHEM KRISTINE C. CENTRAL INDEX KEY: 0001662454 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37648 FILM NUMBER: 18879893 MAIL ADDRESS: STREET 1: 1301 HARBOR BAY PARKWAY CITY: ALAMEDA STATE: CA ZIP: 94502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoCyte Corp CENTRAL INDEX KEY: 0001642380 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 271041563 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1010 ATLANTIC AVENUE STREET 2: SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 BUSINESS PHONE: 510-775-0515 MAIL ADDRESS: STREET 1: 1010 ATLANTIC AVENUE STREET 2: SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-05-23 0 0001642380 OncoCyte Corp OCX 0001662454 MECHEM KRISTINE C. 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 0 1 0 0 VP of Marketing Option to Purchase Common Stock 2.35 2018-05-23 4 A 0 125000 0.00 A 2028-05-22 Common Stock 125000 125000 D Option to Purchase Common Stock 4.70 2027-02-16 Common Stock 67500 67500 D Option to Purchase Common Stock 3.06 2026-02-15 Common Stock 60000 60000 D Option to Purchase Common Stock 3.16 2025-08-03 Common Stock 100000 100000 D These options vest as to one-third of the shares on each of the completion of the clinical utility study for OncoCyte's DetermaVu product candidate, the filing of the Medicare dossier for the Medicare local coverage determination, and obtaining a Medicare local coverage determination for OncoCyte's DetermaVu product candidate. One quarter of the options vested on February 16, 2018, and the balance shall vest thereafter in 36 monthly installments upon the completion of each month of continuous employment. One quarter of the options vested on February 15, 2017, and the balance shall vest thereafter in 36 monthly installments upon the completion of each month of continuous employment. One quarter of the options vested on August 3, 2016, and the balance shall vest thereafter in 36 monthly installments upon the completion of each month of continuous employment. /s/Kristine C. Mechem 2018-06-01